Curaleaf Holdings (CURLF) Other Operating Expenses (2019 - 2026)
Curaleaf Holdings (CURLF) recorded quarterly Other Operating Expenses of $43.3 million in Q1 2026, down 99.97% quarter-over-quarter from $158.8 billion in Q4 2025, and up 8.31% on a YoY basis from $40.0 million in Q1 2025.
Curaleaf Holdings (CURLF) Other Operating Expenses (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Other Operating Expenses history runs 8 years deep, the most recent figure standing at $43.3 million for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 8.31% year-over-year to $43.3 million; the TTM figure through Mar 2026 stood at $308.0 billion (up 158924.39% YoY), while the FY2025 annual figure was $93.2 million, down 18.37% from the prior year.
- Other Operating Expenses was $43.3 million for Q1 2026 at Curaleaf Holdings, down from $158.8 billion in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $158.8 billion in Q4 2025 to a low of $33.4 million in Q3 2022.
- Historically, Other Operating Expenses has averaged $30.0 billion across 5 years, with a median of $43.4 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Other Operating Expenses surged 366177.2% in 2023, then sank 99.95% in 2024.
- A 5-year view of Other Operating Expenses shows it stood at $38.8 million in 2022, then soared by 366177.2% to $142.1 billion in 2023, then tumbled by 99.95% to $65.3 million in 2024, then soared by 243083.75% to $158.8 billion in 2025, then plunged by 99.97% to $43.3 million in 2026.
- The last three Other Operating Expenses figures came in at $43.3 million (Q1 2026), $158.8 billion (Q4 2025), and $45.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.33 Mn |
| Dec 31, 2025 | 158.77 Bn |
| Sep 30, 2025 | 45.53 Mn |
| Jun 30, 2025 | 149.16 Bn |
| Mar 31, 2025 | 40.01 Mn |
| Dec 31, 2024 | 65.29 Mn |
| Sep 30, 2024 | 44.99 Mn |
| Jun 30, 2024 | 43.41 Mn |
| Mar 31, 2024 | 43.81 Mn |
| Dec 31, 2023 | 142.13 Bn |
| Sep 30, 2023 | 37.72 Mn |
| Jun 30, 2023 | 43.33 Mn |
| Dec 31, 2022 | 38.80 Mn |
| Sep 30, 2022 | 33.45 Mn |
| Jun 30, 2022 | 36.12 Mn |
| Dec 31, 2021 | 32.35 Mn |
| Sep 30, 2021 | 38.55 Mn |
| Jun 30, 2021 | 42.26 Mn |
| Mar 31, 2021 | 24.63 Mn |
| Dec 31, 2020 | 34.16 Mn |